ABCL (STOCKS)
AbCellera Biologics Inc. Common Shares
$10.985000
+0.630000 (+6.08%)
Prev close: $10.355000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Carl Lars G. Hansen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,982.32M
- Employees
- 596
- P/E (TTM)
- -19.01
- P/B (TTM)
- 3.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.18 | $-0.15 | -0.0343 | -23.54% |
|
Mar 2026 (Q1)
|
$-0.14 | $-0.20 | +0.0596 | +29.86% |
|
Dec 2025 (Q4)
|
$-0.03 | $-0.18 | +0.1475 | +83.10% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.17 | -0.0179 | -10.40% |
Financial Statements
| Revenues | $66.17M |
| Benefits Costs and Expenses | $262.94M |
| Costs And Expenses | $262.94M |
| Nonoperating Income/Loss | $28.39M |
| Operating Expenses | $291.33M |
| Research and Development | $197.77M |
| Other Operating Expenses | $78.18M |
| Operating Income/Loss | -$225.16M |
| Income/Loss From Continuing Operations After Tax | -$164.66M |
| Income/Loss From Continuing Operations Before Tax | -$196.77M |
| Income Tax Expense/Benefit | -$32.11M |
| Net Income/Loss | -$164.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$164.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$164.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.54 |
| Diluted Earnings Per Share | -$0.54 |
| Basic Average Shares | 603,545,710 |
| Diluted Average Shares | 603,545,710 |
| Assets | $1.31B |
| Current Assets | $679.23M |
| Cash | $540.10M |
| Accounts Receivable | $38.42M |
| Inventory | $7.58M |
| Other Current Assets | $93.13M |
| Noncurrent Assets | $628.35M |
| Intangible Assets | $36.53M |
| Other Non-current Assets | $591.82M |
| Liabilities | $411.56M |
| Current Liabilities | $53.19M |
| Wages | $6.08M |
| Other Current Liabilities | $47.11M |
| Noncurrent Liabilities | $358.37M |
| Equity | $896.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $896.02M |
| Liabilities And Equity | $1.31B |
| Net Cash Flow From Operating Activities | -$94.94M |
| Net Cash Flow From Operating Activities, Continuing | -$94.94M |
| Net Cash Flow From Investing Activities | $97.89M |
| Net Cash Flow From Investing Activities, Continuing | $97.89M |
| Net Cash Flow From Financing Activities | $25.07M |
| Net Cash Flow From Financing Activities, Continuing | $25.07M |
| Exchange Gains/Losses | -$722.00K |
| Net Cash Flow | $27.30M |
| Net Cash Flow, Continuing | $28.02M |
| Comprehensive Income/Loss | -$165.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$165.15M |
| Other Comprehensive Income/Loss | -$57.61M |